- Home
- GFF vs CRNX Comparison
GFF vs CRNX Comparison
Compare GFF & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GFF
- CRNX
- Stock Information
- Founded
- GFF 1959
- CRNX 2008
- Country
- GFF United States
- CRNX United States
- Employees
- GFF N/A
- CRNX N/A
- Industry
- GFF Building Products
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- GFF Industrials
- CRNX Health Care
- Exchange
- GFF Nasdaq
- CRNX Nasdaq
- Market Cap
- GFF 3.2B
- CRNX 2.8B
- IPO Year
- GFF N/A
- CRNX 2018
- Fundamental
- Price
- GFF $81.36
- CRNX $35.61
- Analyst Decision
- GFF Strong Buy
- CRNX Strong Buy
- Analyst Count
- GFF 4
- CRNX 7
- Target Price
- GFF $99.00
- CRNX $74.33
- AVG Volume (30 Days)
- GFF 424.4K
- CRNX 1.0M
- Earning Date
- GFF 08-06-2025
- CRNX 08-07-2025
- Dividend Yield
- GFF 0.90%
- CRNX N/A
- EPS Growth
- GFF N/A
- CRNX N/A
- EPS
- GFF 1.49
- CRNX N/A
- Revenue
- GFF $2,517,417,000.00
- CRNX $1,392,000.00
- Revenue This Year
- GFF N/A
- CRNX $489.51
- Revenue Next Year
- GFF $2.06
- CRNX $661.93
- P/E Ratio
- GFF $53.56
- CRNX N/A
- Revenue Growth
- GFF N/A
- CRNX 0.51
- 52 Week Low
- GFF $60.97
- CRNX $24.10
- 52 Week High
- GFF $86.73
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- GFF 63.73
- CRNX 70.32
- Support Level
- GFF $75.08
- CRNX $30.25
- Resistance Level
- GFF $78.36
- CRNX $35.21
- Average True Range (ATR)
- GFF 1.86
- CRNX 1.41
- MACD
- GFF 0.70
- CRNX 0.65
- Stochastic Oscillator
- GFF 92.21
- CRNX 95.62
About GFF Griffon Corporation
Griffon Corp manufactures and markets residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. It also provides non-powered landscaping products for homeowners and professionals. Its operating segments include Consumer and Professional Products: is a provider of branded consumer and professional tools; residential, industrial and commercial fans; home storage and organization products; and Home and Building Products conducts its operations through Clopay Corporation (Clopay). Clopay is the manufacturer and marketer of garage doors and rolling steel doors in North America. The company generates a majority of its revenue from the Home and Building Products segment. Operates in USA, Europe, Canada, Australia, and Others.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.